Rethinking the Build vs Buy Model in Radiopharmaceutical Manufacturing

This session will feature an expert-delivered presentation, before opening to a facilitated audience discussion

  • Comparing in-house manufacturing vs CDMO reliance in the context of radiopharmaceutical complexity
  • Exploring strategies for combining internal capabilities with strategic CDMO partnerships to ensure continuity of supply while maintaining flexibility
  • Evaluating how facility decisions impact control, flexibility, and scalability across the supply chain
  • Identifying hidden constraints beyond infrastructure, particularly workforce availability and expertise